These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 4155334)

  • 1. The effects of a new beta-adrenoceptor blocking compound, tolamolol, on haemo-dynamics and myocardial function in man.
    Hillis WS; Hutton I; Lawrie TD; Lorimer AR; Reid JM
    Br J Pharmacol; 1974 May; 51(1):15-9. PubMed ID: 4155334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of tolamolol versus propranolol on cardiovascular haemodynamics in patients with angina.
    Aronow WS; March H; Vangrow JS; Cassidy J; Kern JC; Khemka M; Vawter M; Pagano J
    Br Heart J; 1974 Nov; 36(11):1078-81. PubMed ID: 4155953
    [No Abstract]   [Full Text] [Related]  

  • 3. Beta receptor blocking and antiarrhythmic properties of tolamolol.
    Bagwell EE; Custy J; Steen RG; Newman WH
    J Pharmacol Exp Ther; 1974 Dec; 191(3):496-505. PubMed ID: 4154378
    [No Abstract]   [Full Text] [Related]  

  • 4. Cardiovascular effects of tolamolol (UK-6558), a new beta-adrenoreceptor blocking drug, in pinealectomized hypertensive rats.
    Karppanen H; Lahovaara S; Mattila MJ
    Ann Med Exp Biol Fenn; 1973 Mar; 51(3):104-11. PubMed ID: 4149365
    [No Abstract]   [Full Text] [Related]  

  • 5. Combined invasive and noninvasive study of left ventricular systolic and diastolic function following acute administration of cicloprolol to subjects with normal cardiac function.
    Bonandi L; Metra M; Niccoli L; Ettori F; Nodari S; Dei Cas L; Visioli O
    Cardiovasc Drugs Ther; 1992 Oct; 6(5):513-7. PubMed ID: 1360256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of S-596, a new beta-adrenoceptor blocking agent on the left ventricular performance of normal subjects during exercise.
    Nishida K; Niki S; Furukawa K; Yamada C; Sugihara H; Katsume H; Ijichi H
    Jpn Heart J; 1985 May; 26(3):437-49. PubMed ID: 2411959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular effects of nipradilol, a beta-adrenoceptor blocker with vasodilating properties.
    Fujii M; Shirasawa Y; Kondo S; Sawanobori K; Nakamura M
    Jpn Heart J; 1986 Mar; 27(2):233-50. PubMed ID: 2873263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative effects of tolamolol and propranolol on cardiac and peripheral circulatory function in patients with coronary artery disease.
    Miller RR; Vismara LA; Mason DT
    Clin Pharmacol Ther; 1975 Jun; 17(6):713-21. PubMed ID: 1095282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Haemodynamic observations with KO. 1366 (bunitrolol), a new beta-adrenergic blocking agent.
    Banim SO; da Silva A; Balcon R
    Curr Med Res Opin; 1977; 4(9):630-4. PubMed ID: 22426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in regional blood flows and myocardial performance after administration of bisoprolol to pigs.
    Verdouw PD; Duncker DJ; Schmeets IO; von Woerkens LJ; Saxena PR
    Eur Heart J; 1987 Dec; 8 Suppl M():71-9. PubMed ID: 2897301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hemodynamic action of talinolol (Cordanum, 02-115), a new beta-receptor blocking substance, in man].
    Wolf P; Feller K; Femmer K
    Pharmazie; 1975 Oct; 30(10):678-81. PubMed ID: 696
    [No Abstract]   [Full Text] [Related]  

  • 12. Efficacy of cardioselective beta adrenergic blockade with intravenously administered tolamolol in the treatment of cardiac arrhythmias.
    Amsterdam EA; Lee G; Morrison S; Tonkin MJ; DeMaria AN; Mason DT
    Am J Cardiol; 1976 Aug; 38(2):195-9. PubMed ID: 7952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isoprenaline- and exercise- induced tachycardia in the assessment of beta-adrenoceptor blocking drugs; a comparison between tolamolol, practolol and propranolol.
    Adam KR; Pullman LG; Scholfield PC
    Br J Pharmacol; 1973 Nov; 49(3):560-3. PubMed ID: 4149697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemodynamic effects of intravenous metoprolol.
    Bourdillon PD; Canepa-Anson R; Rickards AF
    Am J Cardiol; 1979 Nov; 44(6):1195-200. PubMed ID: 495515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of catecholamine infusions on myocardial blood flow, metabolic heat production and on general haemodynamics, before and after alprenolol (H56-28), in anaesthetized cats.
    Parratt JR; Wadsworth RM
    Br J Pharmacol; 1970 May; 38(3):554-71. PubMed ID: 4392541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemodynamic effects of intravenous timolol in coronary artery disease.
    Chew CY; Collett J; Shah PK; Singh BN
    Clin Pharmacol Ther; 1979 Sep; 26(3):330-8. PubMed ID: 466927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrapericardial beta-adrenergic blockade with esmolol exerts a potent antitachycardic effect without depressing contractility.
    Moreno R; Waxman S; Rowe K; Verrier RL
    J Cardiovasc Pharmacol; 2000 Dec; 36(6):722-7. PubMed ID: 11117371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Does chronic oral treatment with beta-receptor blockers have an effect on positive inotropic therapy of coronary patients with adrenaline after extracorporeal circulation?].
    Günnicker M; Brinkmann M; Freund U; Piotrowski J; Schieffer M; Velser U
    Herz; 1995 Dec; 20(6):399-411. PubMed ID: 8582699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of catheter-tip velocity--pressure transducer to evaluate left ventricular function in man: effects of intravenous propranolol.
    Klinke WP; Christie LG; Nichols WW; Ray ME; Curry RC; Pepine CJ; Conti CR
    Circulation; 1980 May; 61(5):946-54. PubMed ID: 7363437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Celiprolol: a positive inotropic beta-adrenoceptor blocking agent in conscious dogs.
    Nganele DM; DeLeonardis VM; Hintze TH
    Br J Pharmacol; 1988 Mar; 93(3):501-8. PubMed ID: 2897217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.